logo
‘Downwinders' Compensation Program Reinstated, Expanded

‘Downwinders' Compensation Program Reinstated, Expanded

Medscapea day ago
When nuclear tests detonated in Nevada during the 1950s and 1960s, a Salt Lake City physician knew danger would blow into town on the wind. So, he set about to protect his family from radiation.
He banned milk from the table for months at a time because strontium-90 could settle on cow pastures and contaminate dairy products. He told his eight children to take iodine pills to protect their thyroid glands from radioactive iodine. And he required them to wear rubber boots when they played on grass after it rained in the days following nuclear tests.
Now, five of the physician's eight children have had cancer, including Brian Moench, MD, who grew up to be an anesthesiologist and is now in his 70s. Two of Moench's own children have had cancer too, both at unusually young ages.
Thanks to a recent decision by Congress to reinstate and expand the Radiation Exposure Compensation Act (RECA) program, now people who lived in northern Utah during the nuclear test era and later developed specific kinds of cancer linked to radiation exposure can apply for the first time for federal compensation — $100,000 each. Those exposed to radiation from tests and nuclear waste in several other regions of the country are also now eligible for compensation.
'Creating this fund was certainly the ethical and moral thing to do,' said Moench, who's fought to expand RECA but can't apply for compensation since the forms of cancer he developed — skin and prostate — aren't covered.
Moench, who's president of Utah Physicians for a Healthy Environment, said the organization's members will alert patients about the program's expansion. Other clinicians across the country, even those in areas far from mid-century nuclear testing, can help get the word out too.
Here are questions and answers about the reinstatement and expansion of the RECA program:
What is the RECA program?
Congress passed the act in 1990 and later expanded it, allowing compensation to people from several affected areas who developed cancer following exposure to radiation in the 1940s, 1950s, and 1960s. 'Downwinders' — those who lived downwind of nuclear testing in certain areas of Utah, Nevada, New Mexico, and Arizona — were eligible for $50,000 payments. Uranium workers in 11 states west of the Mississippi River could get $100,000, and onsite nuclear testing workers such as members of the military were eligible for $75,000.
The eligible cancers for downwinders are blood cancers (leukemias with the exception of chronic lymphocytic leukemia [CLL], multiple myeloma, and non-Hodgkin's lymphomas) and a long list of solid organ cancers such as thyroid, breast, stomach, brain, lung, colon, and liver cancers.
As of July 2025, 27,309 downwinders received $1.4 billion in compensation, along with 5768 onsite nuclear testing workers ($422 million in compensation), 7088 uranium miners ($708 million), 1982 uranium millers ($198 million), and 433 ore transporters ($43 million).
In total, the program has awarded $2.7 billion.
What's the status of the program?
While there was bipartisan support to extend and expand RECA upon its expiration in June 2024, Congress failed to act. The program ended, and no further applications could be accepted.
Politicians in affected states raised the alarm and pushed to renew RECA. Legislation was tucked into the mammoth 'One Big Beautiful Bill Act,' which passed Congress largely upon party lines and was signed by the president in July 2025.
What has changed regarding eligibility and compensation?
Lilly Adams, senior outreach coordinator with the Union of Concerned Scientists, which supports expanding the program, highlighted these changes in the reinstated RECA program in an interview:
Expanded downwinder eligibility: Eligible downwinders now include those who lived in all of New Mexico, Utah, and Idaho and all of Mohave County in Arizona. (Previously, none of Idaho and only parts of New Mexico, Utah, and Mohave County were included.)
There's also a change regarding coverage of downwinders who developed forms of leukemia other than CLL.
Now, downwinders who were exposed to radiation during listed times and developed leukemia — except CLL — are eligible for compensation. Previously, exposure had to occur before 21 years of age. CLL continues to not be one of the eligible types of cancer.
Expanded uranium worker eligibility: People who worked as a uranium miller or miner, ore transporter, or core driller — or were involved in remediation efforts at a uranium mine or mill — are eligible for compensation. Eligibility for core drillers and remediation workers is new.
The eligible period has expanded to 1942-1990 from 1947-1971, and the list of eligible diseases has expanded for certain uranium workers.
New nuclear production/waste eligibility: People who live in communities in specific zip codes in Missouri, Tennessee, Kentucky, and Alaska around nuclear waste/production sites are now eligible for compensation.
They must have lived in the areas for at least 2 years after January 1, 1949. The eligible diseases, which must have an onset at least 2 years after the date of initial exposure, are multiple myeloma; lymphoma; cancer of the thyroid, breast, esophagus, stomach, pharynx, small intestine, pancreas, bile ducts, gall bladder, salivary gland, bladder, brain, colon, ovary, bone, renal, liver (except if cirrhosis or hepatitis B is indicated), lung, or leukemia (only if exposure occurred after the age of 20 years).
These people can receive either $50,000 or the total of all out-of-pocket medical expenses related to their qualifying illness, whichever is higher. Survivors may receive $25,000 if the affected person has died.
Reduced residency requirements: Outside of New Mexico, downwinders now need to prove only 1 year of residence in affected areas from January 21, 1951, to November 6, 1962, or for the entire period from June 30, 1962, to July 31, 1962, which is down from the previous 2-year requirement.
Previously, there was a gap of ineligibility between 1958 and 1962.
For New Mexico only, eligible people must have lived for at least 1 year in the state between September 24, 1944, and November 6, 1962.
Increased compensation: Downwinders will now receive $100,000 instead of the previous $50,000, while onsite nuclear test participants will see payments increase from $75,000 to $100,000. Uranium miners will continue to receive $100,000, with the program now extended to include core drillers.
New deadline: Eligible individuals must submit claims by December 31, 2027. The program will end on December 31, 2028.
What if affected people have died?
Their descendants are eligible for compensation.
What should clinicians know about this program?
In an interview, Laura Shaw, MD, an associate professor and principal investigator of Nevada's radiation exposure screening program at the University of Nevada, Las Vegas, noted that eligible people may have moved to other states since they were exposed to radiation.
'Doctors need to encourage patients to apply ASAP,' she said. In addition, 'doctors need to specifically document specific diagnosis for any cancers to help prove eligibility and for potential changes to covered cancers in the future.'
She also cautioned that 'there are disreputable people out there charging to help file claims when there are free programs to assist people file.'
Shaw also highlighted the Radiation Exposure Screening and Education Program, which is separate from RECA and has not been discontinued.
Downwinders, uranium workers, and on-site participants can get free health screenings at clinics in Arizona, Colorado, Nevada, New Mexico, and Utah. Also, health providers can get funding to offer screenings in those states and Idaho, North Dakota, Oregon, South Dakota, Texas, Washington, and Wyoming.
The screenings cover cancer and noncancer conditions. 'We continue to get contacted by individuals who in these communities who have never heard of this program, even though we've been holding clinics since 2005,' Shaw said in an earlier interview. 'Despite outreach activities and advertising through newspapers and radio, we find the most successful method of reaching these patients is through word of mouth — either from other patients or their doctors. That is why we feel it is so important to reach other physicians as well.'
It's unclear whether the Radiation Exposure Screening and Education Program will be geographically expanded to reflect the growth in eligibility for the RECA program.
What about other areas of the country?
Initially, congressional legislation expanded eligibility for downwinder compensation to all of Colorado, Montana, and Guam and new parts of Arizona and Nevada, Adams said. But those provisions were not included in the final One Big Beautiful Bill Act, Shaw said.
She noted that earlier legislation included all of Nevada's Clark County. Clark County, home to Las Vegas, was a prime spot for nuclear testing. This means that only part of the county will continue to be covered.
Why were these areas left out? 'It's probably pretty safe to say it was money,' she said, but discussions happened behind the scenes, and 'this is all sort of a mystery to us.'
In another change from previous legislation, a provision was removed that would have made downwinders with CLL eligible for compensation.
The Union of Concerned Scientists will continue advocating for wider compensation for radiation exposure and the extension of the program beyond its scheduled end date, Adams said.
How are people reacting to the expansion of the compensation program?
In Guam, downwinders were disappointed to not be included. Robert Celestial, president of the Pacific Association for Radiation Survivors, told The Guam Daily Post that 'our cancers are no different than cancers for those in the states. And we just got to continue on and try again.'
Shaw, the Nevada associate professor, is disappointed that the new legislation boosts compensation for downwinders, but only for those who apply going forward.
'Some patients who filed before the sunset in 2024 are upset that now the reimbursement is higher, and they rushed to get in their claim,' she said. 'There should be a retroactive increase in compensation if the individual is still living.'
As for Moench, the Utah advocate physician, the compensation news is good — to a point.
Two of his sisters, who had breast cancer, will be eligible for compensation since the disease is covered. An older brother who had cancer of the small intestine is also eligible.
In the big picture, however, 'the money that's been paid out is a fraction of what should have been paid out. It doesn't compensate for the deaths that have been caused, for the misery and the suffering.'
And, he said, the program doesn't cover much of the US that was exposed to radiation from the nuclear tests of the 1940s, 1950s, and 1960s.
A 2023 study suggested that radiation from 94 nuclear weapon tests in the Southwest from 1945 to 1962 reached 46 states along with Canada and Mexico.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers
iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers

Yahoo

time25 minutes ago

  • Yahoo

iCRYO's CEO and CAO to Join Vitality Business Summit 2025 as Featured Speakers

DALLAS, Aug. 6, 2025 /PRNewswire/ -- iCRYO, a leading health, wellness, and longevity franchise, is excited to announce that its CEO and Co-Founder, Kyle Jones, and Chief Administrative Officer (CAO), Scott Briner, will be featured speakers at the Vitality Business Summit 2025. The summit, scheduled for October 3-5, 2025, at the Hilton DFW Lakes Executive Conference Center in Dallas, Texas, is organized and hosted by brothers Chris and Brad Himel of Himel Health, longtime consultants for health and wellness clinics. Leveraging their network, they are bringing together brand entrepreneurs, clinic owners, and other health enthusiasts to shape the future of health and wellness. Emphasizing practical solutions over passing trends, The Vitality Business Summit promises to equip attendees with the tools to build scalable, purpose-driven businesses. Kyle W. Jones, as a pioneer in cryotherapy and holistic wellness going back to 2015, will join a host of other accomplished leaders in the industry, including acclaimed speaker and author Tim Storey, motivational speaker Jenn Drummond, BrainTap founder Dr. Patrick Porter, business coach Raquel Diehm, and OxyHealth CEO Dr. Mayur Patel, to name a few. "I'm thrilled to speak at the Vitality Business Summit and share the strategies that have fueled iCRYO's growth while keeping wellness accessible," said Jones. "At the same time, this event is a catalyst for change, with innovation and adoption moving ever faster in this space. This summit offers us a chance to keep our finger on the pulse and connect with other professionals building businesses that will make a lasting impact." iCRYO's CAO and former hospital CEO Scott Briner echoed Jones' thoughts, adding, "I'm honored to join Kyle as a speaker and represent iCRYO at the Vitality Business Summit this fall. We've developed what we believe is the new industry-standard for medical care in a retail environment, and we're proud to share it with the world any chance we get. However, we're always looking to learn, grow, and improve iCRYO's service and offerings, and this event gives us that chance." The summit caters to a diverse audience, from solo practitioners to multi-unit clinic owners, offering unparalleled opportunities to learn sales and marketing frameworks used by successful clinics, network with world-class experts, explore dozens of vendors showcasing the latest in wellness modalities and therapies, develop a tailored growth plan, and create lasting partnerships. Early Bird pricing offers up to 50% off General Admission and 33% off VIP tickets, which include a VIP Lunch with speakers on Sunday. Attendees are encouraged to secure their spots now as both General Admission and VIP tickets are going fast with these early bird offers. Event Details: Date: October 3-5, 2025 Location: Hilton DFW Lakes Executive Conference Center, Dallas, Texas Tickets: Available at About iCRYO Founded in 2015, iCRYO's mission is to elevate the quality of life of its team members, guests, and franchisees by providing affordable, professional, and convenient personal health services while raising the standard as a global wellness brand. To learn more about its services, locations, and franchise opportunities, visit iCRYO Media Contact Robbie JenkinsDirector of View original content to download multimedia: SOURCE iCRYO Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RFK Jr.'s slander of mRNA technology will harm Americans
RFK Jr.'s slander of mRNA technology will harm Americans

Washington Post

time27 minutes ago

  • Washington Post

RFK Jr.'s slander of mRNA technology will harm Americans

Robert F. Kennedy Jr.'s decision to cancel almost $500 million in contracts for projects to develop vaccines using mRNA technology underscores perhaps the greatest harm that he might inflict on the nation with his anti-vaccine ideology. The disparagement of existing immunizations by the health and human services secretary is dangerous on its own, in that it might persuade people to forego recommended shots and reduce herd immunity against diseases. But potentially even worse are the impacts that will be harder to see: the diseases that public health officials won't be able to fight because of the lifesaving innovations he is cutting short. Kennedy's resistance against mRNA vaccines is without evidence. In fact, the technology — which instructs the body's cells to produce a harmless bit of virus that is then used to train the immune system, as opposed to using weakened or dead versions of a virus — delivered arguably the most important achievement of President Donald Trump's first term: the production of effective vaccines against the novel coronavirus within the span of a few months. Such speed was practically unheard-of in biomedical research. Thanks to the urgency created by Operation Warp Speed, the federal government was able to mount an impressive vaccination rollout that boosted the population's immunity to the coronavirus just when it was needed. As with any medical treatment, these vaccines were not perfect. In very rare instances among adolescents, they resulted in a serious side effect known as myocarditis, or inflammation of the heart muscle. Their effectiveness also waned over time as the coronavirus mutated, as is the case with vaccines for other respiratory diseases. But there can be no doubt: These vaccines saved millions of lives. Kennedy absurdly claimed in a video statement that 'mRNA vaccines don't perform well against viruses that infect the upper respiratory tract.' He further claimed that a single mutation in a virus can render vaccines 'ineffective.' He even went so far as to argue that this effect 'encourages' mutations and could 'prolong' a pandemic. This is just plain wrong, as the covid pandemic demonstrated. The effectiveness of mRNA coronavirus vaccines might have diminished over time, but they continued to protect people against severe illness over the course of multiple strains. In fact, the Centers for Disease Control and Prevention continued to recommend the shots for vulnerable populations for that reason, and manufacturers updated boosters to combat new strains. Giving up on this game-changing technology will slow down scientific innovation, leaving Americans more vulnerable to diseases. Kennedy just canceled or altered 22 mRNA projects that were supported by the Biomedical Advanced Research and Development Authority. On the chopping block are vaccine developments for several respiratory illnesses. That includes a project to defend the country against the H5N1 bird flu virus, which scientists warn could spiral into a deadly pandemic if someone contracts it while also infected with the seasonal flu virus. And that's just the beginning. Researchers are eager to deploy mRNA technology against a slew of other hard-to-tackle pathogens, from hepatitis C to HIV to malaria. There are even efforts to use this approach to activate the immune system to attack cancer cells and to treat other genetic diseases. Some scientists have suggested this research could also be essential for national security, as it might help defend against attacks from biological weapons. Calling Kennedy's latest actions shortsighted understates the gravity of his slander. Americans will bear the cost of his rejection of science.

USAID And PEPFAR Cuts Could Lead To Massive Loss Of Life Overseas
USAID And PEPFAR Cuts Could Lead To Massive Loss Of Life Overseas

Forbes

time27 minutes ago

  • Forbes

USAID And PEPFAR Cuts Could Lead To Massive Loss Of Life Overseas

A Lancet paper published in July evaluates data to illustrate the importance of roughly two decades of American humanitarian aid offered through the United States Agency for International Development and the President's Emergency Plan for AIDS Relief. The piece subsequently projects what the future could look like in light of the steep cuts imposed by President Trump to USAID and PEPFAR. Authors estimate that USAID-funded programs have helped prevent more than 91 million deaths globally in the past 20 years, including 30 million fatalities among children. Projections suggest that ongoing deep funding cuts—combined with the dismantling of the agency—could result in more than 14 million additional deaths by 2030. On inauguration day, President Trump ordered a sweeping 90-day spending freeze on virtually all U.S. foreign aid, including many forms of health and food assistance. An independent agency, USAID, was largely gutted. The USAID undertakes a wide range of activities, which include among other things food aid and distribution (often in conflict zones), clean water provision, maternal and infant health support, mass administration of rehydration salts for children suffering from diarrhea, malaria prevention and treatments and polio vaccinations in countries where the disease is still endemic. The agency was established under President John F. Kennedy in the early 1960s to administer humanitarian aid programs around the world. Congress appropriates funds for USAID's operations. The agency employed roughly 10,000 people, two-thirds of whom worked overseas. In fiscal year 2024, the agency received more than $44 billion in federal funding. Most of that money was spent in Asia, sub-Saharan Africa and Europe (primarily on humanitarian efforts in Ukraine). While a considerable sum, it merely accounts for 0.4% of the entire federal budget. The Trump administration has slashed 86% of USAID funding. Only a small fraction of aid programs remains in place. The employee head count is now under 500. As carried out by successive administrations since Bush, including the first Trump administration, PEPFAR represented the largest commitment in history by any nation to address a single disease, HIV/AIDS. But gradually the second Trump administration is unraveling this initiative, too. KFF reported that while PEPFAR received a limited waiver on Feb. 1, allowing it to continue certain 'life-saving HIV services,' the waiver doesn't include essential pre-exposure prophylaxis for anyone other than pregnant and breastfeeding women. The State Department has sought $2.9 billion in funding to continue HIV-AIDS programs in the next fiscal year—considerably lower than PEPFAR's current budget of $4.1 billion. Moreover, USAID was the main agency working on behalf of PEPFAR. Without USAID and its staff, PEPFAR's implementation capacity has been seriously affected. Going forward, the Trump administration intends to transform PEPFAR from an aid program to one that is aligned with its 'America First' priorities. The plan, as described by the New York Times, outlines the administration's intentions to 'transition' countries off of PEPFAR, in some cases within two years. The program would in essence no longer be involved in aid and saving lives overseas. Rather, it would focus on detecting outbreaks that could threaten the U.S. and at the same time create new markets for American drugs and technologies. On the ground, journalists are painting a grim picture of the implications of the drastic curtailment in U.S. aid. A story in America Magazine, for example, describes in detail the local impact in Eswatini, a country in Southern Africa, of the gutting of USAID and reductions in PEPFAR. Cuts have severely limited access to HIV treatments and testing in clinics. During the height of the HIV/AIDS pandemic, the population of Eswatini plummeted, and life expectancy dropped from 61 in 1988 to 44 by 2003. It reverted to 61 in 2023, thanks in large part to USAID and PEPFAR. But now the gains in health outcomes are in jeopardy. The ramifications of a greatly diminished U.S. presence in health aid, international development and disaster assistance could be profound, specifically around the global humanitarian programs which rely on USAID. In terms of international assistance, the U.S. was by far the world's largest donor. The U.S. spent $68 billion on international aid in 2023. And the Trump administration's actions are also affecting what is termed the President's Malaria Initiative, an organization also founded by former President Bush. Through the work of this entity, the U.S. had become the global leader in donating to anti-malaria programs and research. According to the New York Times, one of Trump's executive orders has led to two-thirds of the staff being let go from the Malaria Initiative. And by pulling out of the World Health Organization, Trump further diminishes the critical role the U.S. plays in combating neglected tropical diseases, such as leishmaniasis, river blindness, Dengue fever and trachoma. These preventable and mostly treatable infectious diseases affect millions of people in tropical regions of the world, causing severe health problems, including anemia, blindness, chronic pain, infertility and bodily disfigurement. Historically, despite the large burden imposed by neglected tropical diseases on many people, they've received a relatively small portion of resources for drug development and treatment distribution. U.S. aid agencies had been filling some of the void. Until now.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store